Comprehensively analysis of immunophenotyping signature in triple-negative breast cancer patients based on machine learning

Comprehensively analysis of immunophenotyping signature in triple-negative breast cancer patients based on machine learning

Immunotherapy is a promising strategy for triple-negative breast cancer (TNBC) patients, however, the overall survival (OS) of 5-years is still not satisfactory. Hence, developing more valuable prognostic signature is urgently needed for clinical practice. This study established and verified an effe...

Full description

Bibliographic Details
Main Authors: Lijuan Tang, Zhe Zhang, Jun Fan, Jing Xu, Jiashen Xiong, Lu Tang, Yan Jiang, Shu Zhang, Gang Zhang, Wentian Luo, Yan Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Pharmacology
Subjects:
triple-negative breast cancer
immunotherapy
immunophenotype
prognosis
chemotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1195864/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1195864/full

Similar Items